Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

米国株投資で幸せ作り

ノボ・ノルディスク新薬CagriSemaに失望?最新データが示す現実

16 Sep 2025

Description

ノボ・ノルディスクがCagriSemaの新データを公開。ウゴービやイーライ・リリーのZepboundと比べて効果が見劣りし、投資家の反応は慎重です。https://beikoku-stock.com/2025/09/17/novo-obesity-drug-cagrisema-data-review/

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.